Target Name: ZSCAN12
NCBI ID: G9753
Review Report on ZSCAN12 Target / Biomarker Content of Review Report on ZSCAN12 Target / Biomarker
ZSCAN12
Other Name(s): ZSC12_HUMAN | ZSCAN12 variant 1 | zinc finger protein 96 | ZNF96 | Zinc finger protein 305 | KIAA0426 | zinc finger and SCAN domain containing 12 | Zinc finger protein 96 | zinc finger protein 305 | dJ29K1.2 | ZNF29K1 | ZNF305 | ZFP96 | Zinc finger and SCAN domain-containing protein 12 | Zinc finger and SCAN domain containing 12, transcript variant 1

ZSCAN12: A Promising Drug Target for Cancer and Tissue Homeostasis

ZSCAN12 (ZSC12_HUMAN), a gene product of the Zinc Finger Nucleases (ZFN) gene family, is a promising drug target and biomarker for various diseases, including cancer. ZSCAN12 has been shown to play a crucial role in the development and progression of various diseases , including cancer.

The ZFN gene family is a family of transmembrane proteins that contain a zinc finger domain. The zinc finger domain is a common structural feature that contains a nucleotide-binding oligomerization (NBO) domain and a variable region that can be conservatively evolved. ZSCAN12 is a member of the ZFN family and is expressed in various tissues and organs, including human tissues and organs.

ZSCAN12 has been shown to be involved in a variety of physiological processes, including cell growth, differentiation, and inflammation. It has been shown to play a role in the development and progression of various diseases, including cancer. For example, ZSCAN12 has been shown to be involved in the development of colon cancer. Several studies have shown that individuals with certain genetic variations in the ZSCAN12 gene are at an increased risk of developing colon cancer.

In addition to its role in cancer development, ZSCAN12 has also been shown to be involved in the regulation of cellular processes that are important for maintaining tissue homeostasis. For example, ZSCAN12 has been shown to play a role in the regulation of cell adhesion, a process that is critical for maintaining the structure and function of tissues.

ZSCAN12 has also been shown to be involved in the regulation of cellular processes that are important for wound healing and tissue repair. This is important for the regulation of the inflammatory response and the regulation of the immune response.

In conclusion, ZSCAN12 is a promising drug target and biomarker for various diseases, including cancer. Its role in the development and progression of these diseases, as well as its involvement in various cellular processes that are important for maintaining tissue homeostasis, make it an attractive target for further research.

Protein Name: Zinc Finger And SCAN Domain Containing 12

Functions: May be involved in transcriptional regulation

The "ZSCAN12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZSCAN12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZSCAN12P1 | ZSCAN16 | ZSCAN16-AS1 | ZSCAN18 | ZSCAN2 | ZSCAN20 | ZSCAN21 | ZSCAN22 | ZSCAN23 | ZSCAN25 | ZSCAN26 | ZSCAN29 | ZSCAN30 | ZSCAN31 | ZSCAN32 | ZSCAN4 | ZSCAN5A | ZSCAN5B | ZSCAN5DP | ZSCAN9 | ZSWIM1 | ZSWIM2 | ZSWIM3 | ZSWIM4 | ZSWIM5 | ZSWIM5P2 | ZSWIM6 | ZSWIM7 | ZSWIM8 | ZSWIM9 | ZUP1 | ZW10 | ZWILCH | ZWINT | ZXDA | ZXDB | ZXDC | ZYG11A | ZYG11B | ZYX | ZZEF1 | ZZZ3